TrialJournal of nuclear medicine : official publication, Society of Nuclear Medicine2012

ACRIN 6665/RTOG 0132 phase II trial of neoadjuvant imatinib mesylate for operable malignant gastrointestinal stromal tumor: monitoring with 18F-FDG PET and correlation with genotype and GLUT4 expression.

Annick D Van den Abbeele et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.